CARDIOLOGÍA
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (37)
2024
-
Factors associated with disease progression in patients with atrial fibrillation and heart failure anticoagulated with rivaroxaban
Clinical Cardiology, Vol. 47, Núm. 2
-
Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives
Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651
2023
-
Cardiac amyloidosis and left atrial appendage closure. The CAMYLAAC study
Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 503-510
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
-
Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry
JACC: Cardiovascular Interventions, Vol. 16, Núm. 10, pp. 1208-1217
-
Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype-phenotype correlation
European heart journal. Cardiovascular Imaging, Vol. 25, Núm. 1, pp. 75-85
-
Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)
Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031
2022
-
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial
European Heart Journal, Vol. 43, Núm. 29, pp. 2783-2797
-
Impact of operatoŕs experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry
IJC Heart and Vasculature, Vol. 38
-
Natural History of MYH7-Related Dilated Cardiomyopathy
Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461
-
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588
-
VA-ECMO support in patients with refractory cardiogenic shock. A 6-year multicenter registry
REC: CardioClinics, Vol. 57, Núm. 1, pp. 7-13
2021
-
Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak
Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 927-937
-
Impact of Comorbidities and Antiplatelet Regimen on Platelet Reactivity Levels in Patients Undergoing Transcatheter Aortic Valve Implantation
Journal of cardiovascular pharmacology, Vol. 78, Núm. 3, pp. 463-473
-
Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic
Cardiovascular Diabetology, Vol. 20, Núm. 1
-
Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival
Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21
-
Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry
Revista Espanola de Cardiologia, Vol. 74, Núm. 3, pp. 216-224
-
ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement
Journal of the American College of Cardiology, Vol. 77, Núm. 17, pp. 2187-2199
-
Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain
REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178
-
Spanish Cardiac Catheterization and Coronary Intervention Registry. 30th Official Report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2020) in the year of the COVID-19 pandemic
Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1096-1106